Intravitreal adenoviral 15-Lipoxygenase-1 gene transfer prevents vascular endothelial growth factor A-induced neovascularization in rabbit eyes

Human Gene Therapy

Volumn 20, Issue 12, 2009, Pages 1679-1686

  Viita, Helena ^a   Kinnunen, Kati ^a   Eriksson, Emmi ^a   Lähteenvuo, Johanna ^a   Babu, Mohan ^a   Kalesnykas, Giedrius ^a   Heikura, Tommi ^a   Laidinen, Svetlana ^a   Takalo, Teemu ^a   Ylä Herttuala, Seppo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

15 LIPOXYGENASE 1; ADENOVIRUS VECTOR; LIPID HYDROPEROXIDE; LIPOXYGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE DISEASE; GENE TRANSFER; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; ARACHIDONATE 15-LIPOXYGENASE; DIABETIC RETINOPATHY; GENE THERAPY; GENETIC VECTORS; HUMANS; LIGANDS; MACULAR DEGENERATION; MICE; NEOVASCULARIZATION, PATHOLOGIC; OPTIC DISK; PPAR GAMMA; RABBITS; RETINAL VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS; ORYCTOLAGUS CUNICULUS;

EID: 74549130049     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.069     Document Type: Article

References (24)

1. Aggarwal, N.T., Holmes, B.B., Cui, L., Viita, H., Ylä-Herttuala, S., and Campbell, W.B. (2007). Adenoviral expression of 15-lipoxygenase-1 in rabbit aortic endothelium: role in arachi-donic acid-induced relaxation. Am. J. Physiol. Heart Circ. Physiol. 292, H1033-H1041.
2. Cathcart, M.K., and Folcik, V.A. (2000). Lipoxygenases and atherosclerosis: Protection versus pathogenesis. Free Radic. Biol. Med. 28, 1726-1734.
3. Chanez, P., Bonnans, C., Chavis, C., and Vachier, I. (2002). 15-lipoxygenase: A Janus enzyme? Am. J. Respir. Cell. Mol. Biol. 27, 655-658.
4. Graham, F.L., Smiley, J., Russell, W.C., and Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74.
5. Kinnunen, K., Korpisalo, P., Rissanen, T.T., Heikura, T., Viita, H., Uusitalo, H., and Ylä-Herttuala, S. (2006). Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer. Acta Physiol. (Oxf). 187, 447-457.
6. Kroschwald, P., Kroschwald, A., Kuhn, H., Ludwig, P., Thiele, B.J., Hohne, M., Schewe, T., and Rapoport, S.M. (1989). Occurrence of the erythroid cell specific arachidonate 15-lipoxygenase in human reticulocytes. Biochem. Biophys. Res. Commun. 160, 954-960.
7. Kuhn, H., and Chan, L. (1997). The role of 15-lipoxygenase in atherogenesis: Pro-and antiatherogenic actions. Curr. Opin. Lipidol. 8, 111-117.
8. Kuhn, H., Walther, M., and Kuban, R.J. (2002). Mammalian arachidonate 15-lipoxygenases: Structure, function, and biological implications. Prostaglandins Other Lipid Mediat. 68-69, 263-290.
9. Laitinen, M., Makinen, K., Manninen, H., Matsi, P., Kossila, M., Agrawal, R.S., Pakkanen, T., Luoma, J.S., Viita, H., Hartikai-nen, J., Alhava, E., Laakso, M., and Ylä-Herttuala, S. (1998). Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum. Gene Ther. 9, 1481-1486.
10. Murata, T., He, S., Hangai, M., Ishibashi, T., Xi, X.P., Kim, S., Hsueh, W.A., Ryan, S.J., Law, R.E., and Hinton, D.R. (2000). Peroxisome proliferator-activated receptor-g ligands inhibit choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 41, 2309-2317.
11. Nadel, J.A., Conrad, D.J., Ueki, I.F., Schuster, A., and Sigal, E. (1991). Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes, leukocytes, and airway cells. J. Clin. Invest. 87, 1139-1145.
12. Nagy, L., Tontonoz, P., Alvarez, J.G., Chen, H., and Evans, R.M. (1998). Oxidized LDL regulates macrophage gene expression through ligand activation of PPARg. Cell 93, 229-240.
13. Panigrahy, D., Singer, S., Shen, L.Q., Butterfield, C.E., Freedman, D.A., Chen, E.J., Moses, M.A., Kilroy, S., Duensing, S., Fletcher, C., Fletcher, J.A., Hlatky, L., Hahnfeldt, P., Folkman, J., and Kaipainen, A. (2002). PPARg ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J. Clin. Invest. 110, 923-932.
14. Pidgeon, G.P., Lysaght, J., Krishnamoorthy, S., Reynolds, J.V., O'Byrne, K., Nie, D., and Honn, K.V. (2007). Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev. 26, 503-524.
15. Rissanen, T.T., Markkanen, J.E., Arve, K., Rutanen, J., Kettunen, M.I., Vajanto, I., Jauhiainen, S., Cashion, L., Gruchala, M., Narvanen, O., Taipale, P., Kauppinen, R.A., Rubanyi, G.M., and Ylä-Herttuala, S. (2003a). Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J. 17, 100-102.
16. Rissanen, T.T., Markkanen, J.E., Gruchala, M., Heikura, T., Puranen, A., Kettunen, M.I., Kholova, I., Kauppinen, R.A., Achen, M.G., Stacker, S.A., Alitalo, K., and Ylä-Herttuala, S. (2003b). VEGF-D is the strongest angiogenic and lym-phangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res. 92, 1098-1106.
17. Sarayba, M.A., Li, L., Tungsiripat, T., Liu, N.H., Sweet, P.M., Patel, A.J., Osann, K.E., Chittiboyina, A., Benson, S.C., Per-shadsingh, H.A., and Chuck, R.S. (2005). Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-g ligand. Exp. Eye Res. 80, 435-442.
18. Sassa, Y., Hata, Y., Aiello, L.P., Taniguchi, Y., Kohno, K., and Ishibashi, T. (2004). Bifunctional properties of peroxisome proliferator- activated receptor g1 in KDR gene regulation mediated via interaction with both Sp1 and Sp3. Diabetes 53, 1222-1229.
19. Sigal, E., Craik, C.S., Highland, E., Grunberger, D., Costello, L.L., Dixon, R.A., and Nadel, J.A. (1988). Molecular cloning and primary structure of human 15-lipoxygenase. Biochem. Bio-phys. Res. Commun. 157, 457-464.
20. van Leyen, K., Duvoisin, R.M., Engelhardt, H., and Wiedmann, M. (1998). A function for lipoxygenase in programmed or-ganelle degradation. Nature 395, 392-395.
21. Viita, H., and Ylä-Herttuala, S. (2000). Effects of lipoxygenases on gene expression in mammalian cells. In Antioxidant and Redox Regulation of Genes. C.K. Sen, H. Sies, and P.A. Baeuerle, eds. (Academic Press, San Diego, CA) pp. 339-358.
22. Viita, H., Markkanen, J., Eriksson, E., Nurminen, M., Kinnunen, K., Babu, M., Heikura, T., Turpeinen, S., Laidinen, S., Takalo, T., and Ylä-Herttuala, S. (2008). 15-Lipoxygenase-1 prevents vascular endothelial growth factor A-and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression. Circ. Res. 102, 177-184.
23. Witmer, A.N., Vrensen, G.F., van Noorden, C.J., and Schlinge-mann, R.O. (2003). Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 22, 1-29.
24. Xin, X., Yang, S., Kowalski, J., and Gerritsen, M.E. (1999). Per-oxisome proliferator-activated receptor g ligands are potent inhibitors of angiogenesis in vitro and in vivo. J. Biol. Chem. 274, 9116-9121.